Experiences of participants in a decentralized antiretroviral therapy program in South Africa during the COVID-19 pandemic.
COVID-19
HIV
South Africa
barriers to care
differentiated service delivery
mental health
Journal
AIDS care
ISSN: 1360-0451
Titre abrégé: AIDS Care
Pays: England
ID NLM: 8915313
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
pubmed:
26
7
2022
medline:
14
2
2023
entrez:
25
7
2022
Statut:
ppublish
Résumé
The COVID-19 pandemic and associated restrictions could adversely affect long-term HIV care. We evaluated the experiences of people receiving antiretroviral therapy (ART) through a decentralized delivery program in South Africa during the COVID-19 pandemic. We telephoned a random subsample of participants enrolled in a prospective cohort study in KwaZulu-Natal in April and May 2020 and administered a semi-structured telephone interview to consenting participants. We completed interviews with 303 of 638 contacted participants (47%); 66% were female, with median age 36y. The most common concerns regarding the COVID-19 pandemic were food running out (121, 40%), fear of becoming infected with COVID-19 (103, 34%), and being unable to work/losing employment or income (102, 34%). Twenty-five (8%) participants had delayed ART pick-up due to the pandemic, while 212 (70%) had new concerns about ART access going forward. Mental health scores were worse during the pandemic compared to baseline (median score 65.0 vs 80.0,
Identifiants
pubmed: 35877987
doi: 10.1080/09540121.2022.2095333
pmc: PMC9873830
mid: NIHMS1820346
doi:
Substances chimiques
Anti-Retroviral Agents
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1413-1419Subventions
Organisme : NIAID NIH HHS
ID : K24 AI141036
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH114997
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007433
Pays : United States
Références
AIDS Behav. 2020 Oct;24(10):2766-2769
pubmed: 32385677
J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):597-606
pubmed: 18285714
AIDS Behav. 2020 Nov;24(11):3010-3013
pubmed: 32488552
AIDS. 2020 Oct 1;34(12):1761-1763
pubmed: 32889851
J Int AIDS Soc. 2021 Jun;24(6):e25704
pubmed: 34105884
AIDS Behav. 2020 Nov;24(11):3006-3009
pubmed: 32451939
AIDS Behav. 2020 Aug;24(8):2250-2252
pubmed: 32328849
AIDS Behav. 2017 Mar;21(3):754-765
pubmed: 27837425
Med Care. 1991 Feb;29(2):169-76
pubmed: 1994148
Med Care. 1998 Feb;36(2):237-43
pubmed: 9475477
J Clin Epidemiol. 2012 Oct;65(10):1107-16
pubmed: 22818947
Med Care. 1999 Dec;37(12):1270-81
pubmed: 10599608
AIDS Behav. 2020 Dec;24(12):3299-3301
pubmed: 32588258
J Int AIDS Soc. 2020 May;23(5):e25503
pubmed: 32378345
AIDS Behav. 2020 Oct;24(10):2751-2753
pubmed: 32347405
Curr HIV/AIDS Rep. 2009 Nov;6(4):224-31
pubmed: 19849966
J Int AIDS Soc. 2022 Jan;25(1):e25877
pubmed: 35077611
Nurs Health Sci. 2008 Dec;10(4):266-72
pubmed: 19128302
AIDS Behav. 2020 Sep;24(9):2473-2476
pubmed: 32333204
J Acquir Immune Defic Syndr. 2020 Sep 1;85(1):66-72
pubmed: 32530862
Lancet HIV. 2020 May;7(5):e308-e309
pubmed: 32272084
Soc Sci Med. 1991;32(6):705-14
pubmed: 2035047
J Assoc Nurses AIDS Care. 2014 Sep-Oct;25(5):405-13
pubmed: 24508174